ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Study: Brain Exercise Lowers Fatigue Symptoms in Multiple Sclerosis

SAN FRANCISCO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Researchers at New York University (NYU) found that a particular set of brain exercises lowered the incidence of the all-too-common symptom of fatigue among patients with Multiple Sclerosis (MS) in a recently published study in the journal Nature: Scientific Reports. The exercises used in the study are from the commercially-available brain exercise app, BrainHQ made by Posit Science.

This is the tenth published study in patients with MS using the BrainHQ exercises. Earlier studies have shown significant gains in processing speed, which is a signature cognitive deficit of MS, as well as in various measures of cognitive function, including the Brief International Cognitive Assessment for MS (BICAMS) and in each of its subtests (speed of processing, visuospatial memory, and verbal learning).

While studies in other populations have found training with BrainHQ exercises improved measures of mood (depressive symptoms, feeling of control) and distress (anxiety, stress and fatigue), this is the first study in MS patients showing an improvement from BrainHQ exercises in measures of fatigue.

“We are grateful for the ongoing work by independent researchers examining the potential usefulness of our plasticity-based BrainHQ exercises in addressing chronic diseases,” said Dr. Henry Mahncke, CEO of Posit Science. “The NYU team continues to be at the forefront of that research in MS.”

The latest study at NYU set out to examine whether transcranial Direct Current Stimulation (tDCS), which provides mild electrical stimulation of the brain, could further improve the benefits from training with BrainHQ by enhancing brain plasticity (i.e., the brain’s ability to change chemically, physically, and functionally). The study used a tDCS headset from Soterix®, and employed the PROMIS fatigue score change as the primary outcome measure and the Modified Fatigue Impact Scale as a secondary fatigue measure.

The 117 study participants were randomized into either a group receiving active tDCS stimulation while training with BrainHQ exercises, or a group using a sham tDCS stimulation while training. Each group was asked to complete thirty 20-minute training sessions over six weeks (for a total of 10 hours of training). 

The researchers found both groups experienced a significant decrease in fatigue over the time period on both measures, but no between group difference. “Both the active and sham tDCS groups experienced reductions in fatigue, with no significant difference between the two groups, suggesting that tDCS does not provide any additional benefit over cognitive training alone in reducing fatigue,” the researchers wrote. They noted the study also confirmed the feasibility and tolerance of the home-based intervention.

BrainHQ exercises have shown benefits in more than 300 studies. Such benefits include gains in cognition (attention, speed, memory, decision-making), in quality of life (depressive symptoms, confidence and control, health-related quality of life) and in real-world activities (health outcomes, balance, driving, workplace activities). BrainHQ is offered by leading health and Medicare Advantage plans, by leading medical centers, clinics, and communities, and by organizations focused on peak performance. Consumers can try a BrainHQ exercise for free daily at https://www.brainhq.com.


Contact: media@brainhq.com

Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.59
-2.88 (-1.17%)
AAPL  259.95
-0.30 (-0.11%)
AMD  217.89
+10.20 (4.91%)
BAC  55.04
-0.15 (-0.27%)
GOOG  336.49
+3.76 (1.13%)
META  626.27
-15.70 (-2.45%)
MSFT  468.00
-9.18 (-1.92%)
NVDA  184.23
-0.71 (-0.38%)
ORCL  201.98
-2.70 (-1.32%)
TSLA  449.93
+0.97 (0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.